SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-061270
Filing Date
2010-06-25
Accepted
2010-06-25 17:28:55
Documents
2
Period of Report
2010-08-12
Effectiveness Date
2010-06-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT c02909def14a.htm DEF 14A 585275
2 GRAPHIC c02909c0245400.gif GRAPHIC 4199
  Complete submission text file 0000950123-10-061270.txt   592679
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 10918391
SIC: 2836 Biological Products, (No Diagnostic Substances)